一周港股IPO：麦济生物、奥克斯电气、挚达科技3家递表，维立志博启动招股

Group 1: Company Filings - Three companies submitted applications to the Hong Kong Stock Exchange (HKEX) from July 14 to July 20, with no companies passing the hearing [1] - Hunan Maijizhi Biotechnology Co., Ltd. focuses on developing innovative biopharmaceuticals for allergic and autoimmune diseases, with a strong pipeline of eight candidate products [2] - Aux Electric Co., Ltd. is one of the top five global air conditioning providers, with a market share of 7.1% in 2024 [3] - Shanghai Zhida Technology Development Co., Ltd. specializes in electric vehicle charging stations, holding a global market share of approximately 9.0% [4] Group 2: Financial Performance - Hunan Maijizhi reported revenues of RMB 8.72 million, RMB 24,000, and RMB 0 for the first three months of 2023, 2024, and 2025, respectively, with R&D expenses of RMB 166 million, RMB 150 million, and RMB 24 million [2] - Aux Electric's revenues for 2022, 2023, and the first quarter of 2025 were RMB 19.528 billion, RMB 24.832 billion, and RMB 9.352 billion, with profits of RMB 1.442 billion, RMB 2.487 billion, and RMB 925 million [3] - Zhida Technology's revenues for 2022, 2023, and the first quarter of 2025 were approximately RMB 697 million, RMB 671 million, and RMB 156 million, with losses of RMB 25.147 million, RMB 58.116 million, and RMB 23.6 million [4] Group 3: IPO Market Insights - The IPO market in Hong Kong saw a significant increase, with 43 companies successfully listed in the first half of 2025, raising HKD 106.7 billion, a 688% increase from the previous year [7] - Over 200 companies have submitted applications to list in Hong Kong, with expectations for 90 to 100 companies to go public in the second half of 2025, raising over HKD 200 billion [8] - Foreign capital is increasingly participating as cornerstone investors in Hong Kong IPOs, with foreign investors accounting for 59.3% of all cornerstone investments in the first half of 2025 [9]